Table 1.
Demography and clinical data of the total population, and comparison between patients without vs. with recurrent vascular events during 36-month follow-up.
|
Total population n = 52 |
Uneventful n = 41 |
Vascular events n = 11 |
p-value | |
|---|---|---|---|---|
| age | 66 ± 8 | 66 ± 8 | 66 ± 9 | 0.937 |
| male, n | 34 | 26 | 8 | 0.564 |
| hypertension, n | 51 | 40 | 11 | 0.601 |
| diabetes mellitus, n | 14 | 10 | 4 | 0.427 |
| smoking, n | 11 | 9 | 2 | 1.000 |
| ESR | 12 (8–18) | 10 (8–16) | 18 (14–29) | 0.063 |
| CRP | 1.9 (0.7–4.6) | 1.8 (0.7–5.0) | 2.2 (1.4–3.35) | 0.614 |
| PLT | 224 (200–260) | 224 (207–251) | 243 (171–300) | 0.805 |
| PAR | 67.9 (63.1–73.4) | 67.8 (62.9–73.5) | 70.0 (64.6–72.6) | 0.614 |
| WBC | 6.8 (5.8–8.0) | 6.6 (5.8–7.9) | 7.4 (5.5–10.6) | 0.420 |
| LAR | 35.7 (23.7–46.3) | 36.2 (24.7–46.4) | 34.4 (24.0–43.5) | 0.806 |
| neutrophil | 61.8 (55.4–66.4) | 62 (56–67) | 58 (51–62) | 0.317 |
| NAR | −1.1 (−4.8–6.5) | 0.9 (−3.9–7.2) | −5.2 [−6.8–(−4.7)] | 0.001 |
Vascular events, recurrent stroke, and de novo acute coronary event; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; PLT, platelet; PAR, platelet antisedimentation rate; WBC, white blood cell; LAR, leukocyte antisedimentation rate; NAR, neutrophil antisedimentation rate. Data are presented as median and 25th−75th percentiles, except age as mean ± SD.